Cannabinoids for rheumatic diseases: anti-inflammatory potential but lacking rigorous evidence
Cannabinoids have anti-inflammatory and pain-relieving properties that could benefit rheumatic disease patients, but systematic reviews of their clinical use are outpacing the actual randomized controlled trials.
Quick Facts
What This Study Found
Cannabinoids may help rheumatic diseases through anti-inflammatory/immunomodulatory activity and pain management. However, reviews are being published faster than trials, often reaching conflicting conclusions. The evidence for efficacy is limited and some data suggest potential harms. Safety concerns include driving risks, workplace safety, and pediatric intoxication.
Key Numbers
Systematic review publications outpacing RCTs. Reviews reach conflicting conclusions about efficacy and safety.
How They Did This
Narrative review discussing advantages and limitations of cannabis for rheumatic conditions, including analysis of the imbalance between reviews and primary research.
Why This Research Matters
Many rheumatology patients use or are curious about cannabis, especially for chronic pain. This review highlights that the enthusiasm has outpaced the evidence, and cannabis was often legalized without going through standard regulatory approval.
The Bigger Picture
Chronic pain is the unmet need driving cannabis interest in rheumatology. Unlike inflammation, which has many treatment options including biologics, chronic pain has fewer effective options, making cannabis an attractive but unproven alternative.
What This Study Doesn't Tell Us
Narrative review. The fundamental problem it identifies (more reviews than trials) means any conclusions are built on a thin foundation.
Questions This Raises
- ?Will future RCTs confirm or refute the benefits suggested by preliminary data?
- ?Which rheumatic conditions are most likely to benefit from cannabinoids?
- ?Can cannabinoids be integrated safely alongside immunomodulatory biologics?
Trust & Context
- Key Stat:
- Reviews outpacing trials, often reaching conflicting conclusions
- Evidence Grade:
- Moderate: balanced narrative review that transparently identifies the limitations of the evidence base.
- Study Age:
- Published in 2019.
- Original Title:
- Cannabinoids in the treatment of rheumatic diseases: Pros and cons.
- Published In:
- Autoimmunity reviews, 18(12), 102409 (2019)
- Authors:
- Sarzi-Puttini, Piercarlo(5), Ablin, Jacob, Trabelsi, Adva, Fitzcharles, Mary-Ann, Marotto, Daniela, Häuser, Winfried
- Database ID:
- RTHC-02279
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Can cannabis help arthritis pain?
There is theoretical support from cannabinoid pharmacology and some preliminary data, but rigorous clinical trials specifically for rheumatic pain are lacking.
Why are there more reviews than actual studies?
It is easier and faster to write a review of existing data than to conduct a new clinical trial. The intense interest in medical cannabis has created an incentive to publish reviews even when the underlying evidence is thin.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02279APA
Sarzi-Puttini, Piercarlo; Ablin, Jacob; Trabelsi, Adva; Fitzcharles, Mary-Ann; Marotto, Daniela; Häuser, Winfried. (2019). Cannabinoids in the treatment of rheumatic diseases: Pros and cons.. Autoimmunity reviews, 18(12), 102409. https://doi.org/10.1016/j.autrev.2019.102409
MLA
Sarzi-Puttini, Piercarlo, et al. "Cannabinoids in the treatment of rheumatic diseases: Pros and cons.." Autoimmunity reviews, 2019. https://doi.org/10.1016/j.autrev.2019.102409
RethinkTHC
RethinkTHC Research Database. "Cannabinoids in the treatment of rheumatic diseases: Pros an..." RTHC-02279. Retrieved from https://rethinkthc.com/research/sarzi-puttini-2019-cannabinoids-in-the-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.